What Is The
BBDRisk Dx™ Test?
BBDRisk Dx™ is the first genomic risk test designed specifically for women diagnosed with precancerous breast tumors. The test assays a unique set of cancer biomarker proteins in the tumor tissue and predicts the likelihood of developing breast cancer in the next five years after diagnosis. The technology in the test is based on over a decade of Research and Development focused on precancerous breast tumor biology. The detailed information about the test can be found in the following sections:
About The BBDRisk Dx™ Test
. Atypical and Non-atypical Hyperplasias and Breast Cancer Risk
. NEW GENOMIC TEST, BBDRisk Dx™, TO ASSESS RISK
. BBDRisk Dx™ Test in Medical Management of Hyperplasias
. Science Behind BBDRisk Dx™ Test Development